Governing Health | Board Compensation Programs
McDermott Will & Emery Health Law Podcast
Release Date: 08/12/2024
McDermott Will & Emery Health Law Podcast
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery are joined by three very special guests from J.P. Morgan, Matt Wedge, Managing Director & Co-Head of Middle Market Healthcare Investment Banking; Michael Smith, Executive Director; and Trey Hanlan, Managing Director. Together, they discuss signals shaping the healthcare investment landscape, from M&A momentum to sector hot spots, and share what they’re watching as we head into the...
info_outlineMcDermott Will & Emery Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Jackie Williams, Director of Research, and Hope Amsterdam, Lead Post-Acute Care Analyst, to unpack the key takeaways from our recent webinar on the 2025 outlook for Home Health, Hospice, Home Care, HME, and Home Medical Supplies. This episode covers deal volume and valuation trends, regulatory and reimbursement developments, growth and consolidation opportunities, and what’s driving strategy and risk across sectors. From PDGM and Medicaid reforms to labor pressures and due...
info_outlineMcDermott Will & Emery Health Law Podcast
In this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head of Health & Life Sciences at McDermott Will & Emery, are joined by Rebecca Springer, Director of Market Development at Bailey & Company, to break down the biggest takeaways from HPE Miami. They dive into the 2025 deal outlook, key macroeconomic drivers and challenges, lender sentiment, emerging deal strategies, and what recent activity reveals about the health of the market. Tune in for expert insights on the risks and opportunities...
info_outlineMcDermott Will & Emery Health Law Podcast
This special quarterly series of the Governing Health podcast with SullivanCotter highlights developments in and offers support to the board’s executive compensation committee in light of the many complex operational, technical, and strategic issues that the committee confronts. In this episode, Michael Peregrine, Tim Cotter, Bruce Greenblatt, Kathy Hastings, and Jeff Holdvogt offer recommendations for the committee to focus on in 2025, including: Establishing appropriate incentive goals in an evolving health system Prioritizing executive succession planning/leadership...
info_outlineMcDermott Will & Emery Health Law Podcast
We’re delighted to offer the latest episode in the Governing Health: Board Dialogue series, featuring Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall. In this episode, Ken and podcast host Michael Peregrine examine some of the most bewildering challenges facing hospital administration in recent years. Against this backdrop of rapid change, a well-informed and prepared board is more critical now than ever before. Ken shares his insight on: Tackling current hospital operation complexities Issues that relentlessly plague hospital...
info_outlineMcDermott Will & Emery Health Law Podcast
The first episode of the new season of Driving the Deal is here! In this episode, Brian Fortune, Senior Managing Director at Farragut Square Group is joined by Carlos Orantes, CEO of Alcanza Clinical Research, and Erik Kistler, Managing Director of Houlihan Lokey’s Healthcare Group, to dive deep into the world of clinical research sites and their growing appeal in the private equity space. They’ll be providing an overview of the clinical research site landscape, covering topics such as: Insights into why private equity has targeted this sector, including key financial trends and...
info_outlineMcDermott Will & Emery Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, sits down with Vikram Sithian, Managing Director and Head of Healthcare Financial Sponsors Coverage at Cantor Fitzgerald, to explore the key trends shaping the healthcare private equity landscape. They discuss the latest in healthcare services dealmaking, delve into subsector activity among sponsors, and highlight the most active areas and emerging themes. The conversation also touches on varying sponsor strategies, the new players entering the healthcare space, and the current state of the...
info_outlineMcDermott Will & Emery Health Law Podcast
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Trey Marinello, Managing Director for Houlihan Lokey’s Healthcare Group, and Chad Schulz, Executive Vice President and Managing Director at Alliant Insurance Services. Live from the Houlihan Lokey Global Healthcare Conference in New York City, they embark on a riveting conversation on the booming private equity interest in employer-sponsored healthcare (ESHC). They discuss the macro drivers attracting investors, key attributes of ESHC companies, and strategies for standing out in a crowded market....
info_outlineMcDermott Will & Emery Health Law Podcast
On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Mark Francis, Managing Director and Global Head of the Healthcare Group at Houlihan Lokey. They discuss the state of healthcare private equity in 2024. Mark shares insights on deal activity, key market impacts, emerging opportunities, and the influence of digital healthcare. He also highlights the big challenges and trends shaping the industry. Finally, we wrap up with Mark’s thoughts on what to expect for the rest of the year.
info_outlineMcDermott Will & Emery Health Law Podcast
In this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. Healthcare Practice Group at McDermott Will & Emery. Together, they debrief the HPE Europe 2024 conference in London, covering key trends, including selective deal activity, biotech and pharma services growth, and the rise of medtech driven by AI. Sharon also highlights the challenges of navigating exits and the regulatory landscape in medtech, as well as the outlook for bioscience deals over the next two years.
info_outlineToday’s podcast examines whether board compensation, if appropriate, is legally feasible and whether healthcare organizations need to implement such programs in order to recruit, retain, and recognize board members. Host Michael Peregrine is joined by guest Bruce Greenblatt, Managing Director at Sullivan Carter. Together they cover a range of considerations for not-for-profit healthcare organizations on the adoption and design of a board compensation program.
Bruce believes that the board compensation programs are both beneficial and necessary, and during the conversation, he shares insights on:
-
Why these programs are experiencing a resurgence in examination and implementation
-
The single greatest factor prompting this discussion
-
Common themes of incorporating this rationale with a strong fact-base
-
Key options for boards at the onset of the design process
-
Compensation options that have proved effective
-
Establishing the reasonableness of a board compensation package
-
Addressing organizational reluctance to adopt director compensation programs
Additional Resources: